Gopal, A K, Schuster, S J, Fowler, N H, Trotman, J, Hess, G, Hou, J-Z, Yacoub, A, Lill, M, Martin, P, Vitolo, U, Spencer, A, Radford, J, Jurczak, W, Morton, J, Caballero, D, Deshpande, S, Gartenberg, G J, Wang, S-S, Damle, R N, Schaffer, M, Balasubramanian, S, Vermeulen, J, Cheson, B D & Salles, G 2018, ' Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study ', J Clin Oncol, vol. 36, pp. 2405-2412 . https://doi.org/10.1200/JCO.2017.76.8853